Abiopharma

🔍 Shesky Craig (Executive)

Company: TMC the metals Co Inc. (TMC)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 187,662 shares of Common Shares (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,396,583.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 166,502 shares of Common Shares (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,563,085.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 208,375 shares of Common Shares (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,771,460.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 187,662 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F5, F5
• Sold 166,502 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 166,501.00 | transaction_form_type: 4 | Footnotes: F4, F6, F6
• Sold 208,375 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 416,750.00 | transaction_form_type: 4 | Footnotes: F4, F7, F7

Footnotes:

• F1: Consists of restricted stock units ("RSUs") that converted to common shares on a one-to-one basis. The RSUs were granted on March 20, 2023 and 1/3 vested on March 20, 2024, 1/3 vested on March 20, 2025 and 1/3 vested on March 20, 2026.
• F2: Consists of RSUs that converted to common shares on a one-to-one basis. The RSUs were granted on March 20, 2024 and 1/3 vested on March 20, 2025 and 1/3 vested on March 20, 2026. The remaining RSUs will vest, subject to continued service through the vesting date, 1/3 of the total award on March 20, 2027.
• F3: Consists of RSUs that converted to common shares on a one-to-one basis. The RSUs were granted on March 20, 2025 and 1/3 vested on March 20, 2026. The remaining RSUs will vest as follows, subject to continued service through each vesting date: 1/3 of the total award on March 20, 2027 and the remaining amount on March 20, 2028.
• F4: Each RSU represents the right to receive one common share upon vesting.
• F5: The RSUs were granted as part of the Issuer's long-term incentive plan and vest over a three-year period as follows, subject to continued service through each vesting date: 1/3 on the first anniversary of March 20, 2023 (the "2023 Grant Date"), 1/3 on the second anniversary of the 2023 Grant Date and 1/3 on the third anniversary of the 2023 Grant Date. All of the RSUs have vested and have been settled as of the date hereof.
• F6: The RSUs were granted as part of the Issuer's long-term incentive plan and vest over a three-year period as follows, subject to continued service through each vesting date: 1/3 on the first anniversary of March 20, 2024 (the "2024 Grant Date"), 1/3 on the second anniversary of the 2024 Grant Date and 1/3 on the third anniversary of the 2024 Grant Date. 2/3 of the RSUs have vested and have been settled as of the date hereof.
• F7: The RSUs were granted as part of the Issuer's long-term incentive plan and vest over a three-year period as follows, subject to continued service through each vesting date: 1/3 on the first anniversary of March 20, 2025 (the "2025 Grant Date"), 1/3 on the second anniversary of the 2025 Grant Date and 1/3 on the third anniversary of the 2025 Grant Date. 1/3 of the RSUs have vested and have been settled as of the date hereof.